US20030133955A1
(en)
*
|
1993-02-22 |
2003-07-17 |
American Bioscience, Inc. |
Methods and compositions useful for administration of chemotherapeutic agents
|
US5439686A
(en)
*
|
1993-02-22 |
1995-08-08 |
Vivorx Pharmaceuticals, Inc. |
Methods for in vivo delivery of substantially water insoluble pharmacologically active agents and compositions useful therefor
|
US6964946B1
(en)
*
|
1995-10-26 |
2005-11-15 |
Baker Norton Pharmaceuticals, Inc. |
Oral pharmaceutical compositions containing taxanes and methods of treatment employing the same
|
US6245805B1
(en)
*
|
1995-10-26 |
2001-06-12 |
Baker Norton Pharmaceuticals, Inc. |
Method, compositions and kits for increasing the oral bioavailability of pharmaceutical agents
|
US8137684B2
(en)
*
|
1996-10-01 |
2012-03-20 |
Abraxis Bioscience, Llc |
Formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof
|
US6458373B1
(en)
*
|
1997-01-07 |
2002-10-01 |
Sonus Pharmaceuticals, Inc. |
Emulsion vehicle for poorly soluble drugs
|
BRPI9810945B8
(pt)
*
|
1997-06-27 |
2021-05-25 |
Abraxis Bioscience Inc |
formulações de agentes farmacológicos, métodos para sua preparação e métodos para uso das mesmas
|
US8853260B2
(en)
*
|
1997-06-27 |
2014-10-07 |
Abraxis Bioscience, Llc |
Formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof
|
CN101579335B
(zh)
*
|
1997-06-27 |
2016-08-03 |
阿布拉科斯生物科学有限公司 |
药剂的制剂及其制备和应用方法
|
AR017979A1
(es)
*
|
1998-02-05 |
2001-10-24 |
Novartis Ag |
Formulaciones farmaceuticas de epotilonas, metodo para su preparacion y el uso de los mismos para la manufactura de un medicamento
|
WO1999049848A1
(fr)
*
|
1998-04-01 |
1999-10-07 |
Rtp Pharma Inc. |
Compositions anticancereuses
|
US6979456B1
(en)
*
|
1998-04-01 |
2005-12-27 |
Jagotec Ag |
Anticancer compositions
|
US7030155B2
(en)
*
|
1998-06-05 |
2006-04-18 |
Sonus Pharmaceuticals, Inc. |
Emulsion vehicle for poorly soluble drugs
|
DE19843968A1
(de)
*
|
1998-09-24 |
2000-04-13 |
Hans Dietl |
Taxane enthaltende pharmazeutische Zubereitung zur intravenösen Applikation und Verfahren zu ihrer Herstellung
|
BR9916063A
(pt)
*
|
1998-12-11 |
2002-01-22 |
Pharmasolutions Inc |
Composições auto-emulsificantes para medicamentos fracamente solúveis em água
|
US6682758B1
(en)
|
1998-12-22 |
2004-01-27 |
The United States Of America As Represented By The Department Of Health And Human Services |
Water-insoluble drug delivery system
|
DE19900054A1
(de)
*
|
1999-01-04 |
2000-07-06 |
Hans Dietl |
Taxane enthaltende stabile und sterile Emulsion und Verfahren zu ihrer Herstellung
|
US6761903B2
(en)
|
1999-06-30 |
2004-07-13 |
Lipocine, Inc. |
Clear oil-containing pharmaceutical compositions containing a therapeutic agent
|
US6294192B1
(en)
|
1999-02-26 |
2001-09-25 |
Lipocine, Inc. |
Triglyceride-free compositions and methods for improved delivery of hydrophobic therapeutic agents
|
US6267985B1
(en)
|
1999-06-30 |
2001-07-31 |
Lipocine Inc. |
Clear oil-containing pharmaceutical compositions
|
US6248363B1
(en)
*
|
1999-11-23 |
2001-06-19 |
Lipocine, Inc. |
Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
|
US6383471B1
(en)
|
1999-04-06 |
2002-05-07 |
Lipocine, Inc. |
Compositions and methods for improved delivery of ionizable hydrophobic therapeutic agents
|
EP1189597A4
(fr)
*
|
1999-06-04 |
2008-06-18 |
Pacira Pharmaceuticals Inc |
Compositions a noyau huileux destinees a la liberation prolongee de medicaments hydrophobes
|
US20030236236A1
(en)
*
|
1999-06-30 |
2003-12-25 |
Feng-Jing Chen |
Pharmaceutical compositions and dosage forms for administration of hydrophobic drugs
|
US6458383B2
(en)
|
1999-08-17 |
2002-10-01 |
Lipocine, Inc. |
Pharmaceutical dosage form for oral administration of hydrophilic drugs, particularly low molecular weight heparin
|
US6309663B1
(en)
|
1999-08-17 |
2001-10-30 |
Lipocine Inc. |
Triglyceride-free compositions and methods for enhanced absorption of hydrophilic therapeutic agents
|
US6982281B1
(en)
*
|
2000-11-17 |
2006-01-03 |
Lipocine Inc |
Pharmaceutical compositions and dosage forms for administration of hydrophobic drugs
|
TW422706B
(en)
|
1999-07-01 |
2001-02-21 |
Wang Iz Rung |
An oil-in-water emulsion type of paclitaxel
|
EP2266607A3
(fr)
|
1999-10-01 |
2011-04-20 |
Immunogen, Inc. |
Des immunoconjugués pour le traitement des cancers.
|
US6720001B2
(en)
|
1999-10-18 |
2004-04-13 |
Lipocine, Inc. |
Emulsion compositions for polyfunctional active ingredients
|
US7732404B2
(en)
*
|
1999-12-30 |
2010-06-08 |
Dexcel Ltd |
Pro-nanodispersion for the delivery of cyclosporin
|
JP2003521545A
(ja)
*
|
2000-02-02 |
2003-07-15 |
フロリダ・ステイト・ユニバーシティ・リサーチ・ファウンデイション・インコーポレイテッド |
改良された溶解性を有するタキサン製剤
|
US6452024B1
(en)
|
2000-02-22 |
2002-09-17 |
Chaichem Pharmaceuticals International |
Process for extraction and purification of paclitaxel from natural sources
|
DE10036871A1
(de)
*
|
2000-07-28 |
2002-02-14 |
Pharmasol Gmbh |
Dispersionen zur Formulierung wenig oder schwer löslicher Wirkstoffe
|
WO2002009695A1
(fr)
*
|
2000-08-02 |
2002-02-07 |
Atossa Healthcare, Inc. |
Emulsions bimodales de taxanes et d'esters de polyalcool de butyrate
|
US7387790B2
(en)
|
2001-06-15 |
2008-06-17 |
Cornerstone Pharmaceuticals |
Pharmaceutical and diagnostic compositions containing nanoparticles useful for treating targeted tissues and cells
|
CN1555253A
(zh)
*
|
2001-09-13 |
2004-12-15 |
������ѧ�����о�Ժ |
化疗栓塞用紫杉醇的油性组合物、制剂及它们的制造方法
|
KR100533458B1
(ko)
*
|
2002-07-20 |
2005-12-07 |
대화제약 주식회사 |
파클리탁셀의 가용화용 조성물 및 그의 제조 방법
|
KR100573289B1
(ko)
*
|
2002-07-20 |
2006-04-24 |
대화제약 주식회사 |
방광내 투여를 통한 방광암치료용 파클리탁셀 조성물 및그의 제조 방법
|
US20040213837A1
(en)
*
|
2002-08-05 |
2004-10-28 |
Sankaram Mantripragada |
Oil-core compositions for the sustained release of hydrophobic drugs
|
TR200502189T1
(tr)
*
|
2002-12-09 |
2007-01-22 |
American Bioscience, Inc. |
Kompozisyonlar ve farmakolojik etken maddelerin aktarımı için yöntemler.
|
US6759539B1
(en)
|
2003-02-27 |
2004-07-06 |
Chaichem Pharmaceuticals International |
Process for isolation and purification of paclitaxel from natural sources
|
WO2005030169A1
(fr)
*
|
2003-10-02 |
2005-04-07 |
Sembiosys Genetics Inc. |
Procedes pour preparer des corps huileux comprenant des principes actifs
|
US20060003002A1
(en)
*
|
2003-11-03 |
2006-01-05 |
Lipocine, Inc. |
Pharmaceutical compositions with synchronized solubilizer release
|
US20050129719A1
(en)
*
|
2003-12-15 |
2005-06-16 |
Yu-Fang Hu |
Concentrated emulsion formulation for silatecan
|
WO2005065677A1
(fr)
*
|
2004-01-09 |
2005-07-21 |
Otsuka Pharmaceutical Factory, Inc. |
Emulsion grasse pour disperser ou dissoudre paclitaxel ou docetaxel
|
WO2005065676A1
(fr)
*
|
2004-01-09 |
2005-07-21 |
Otsuka Pharmaceutical Factory, Inc. |
Emulsion grasse contenant paclitaxel ou docetaxel
|
US8557861B2
(en)
*
|
2004-09-28 |
2013-10-15 |
Mast Therapeutics, Inc. |
Low oil emulsion compositions for delivering taxoids and other insoluble drugs
|
CN100462076C
(zh)
*
|
2005-01-20 |
2009-02-18 |
江苏正大天晴药业股份有限公司 |
供静脉用长春花生物碱的稳定水包油乳剂及其制备方法
|
CN100333722C
(zh)
*
|
2005-03-11 |
2007-08-29 |
江苏正大天晴药业股份有限公司 |
静脉用棓丙酯的稳定水包油乳剂及其制备方法
|
JP4929158B2
(ja)
*
|
2005-03-14 |
2012-05-09 |
株式会社大塚製薬工場 |
難水溶性薬物を含有する医薬組成物
|
US20070032438A1
(en)
*
|
2005-08-02 |
2007-02-08 |
Tty Biopharm Company Limited |
Pharmaceutical compositions containing taxanes and methods for preparing the pharmaceutical compositions
|
TWI376239B
(en)
*
|
2006-02-01 |
2012-11-11 |
Andrew Xian Chen |
Vitamin e succinate stabilized pharmaceutical compositions, methods for the preparation and the use thereof
|
WO2008058366A1
(fr)
*
|
2006-09-28 |
2008-05-22 |
Université de Montréal |
Émulsions d'huile dans l'eau, procédés d'utilisation de celles-ci, procédé de préparation de celles-ci et kits comprenant celles-ci
|
EP2025333A1
(fr)
*
|
2007-08-14 |
2009-02-18 |
Pharmatex Italia Srl |
Formules pharmaceutiques injectables de taxoïdes
|
US20090087460A1
(en)
*
|
2007-10-02 |
2009-04-02 |
Hamamatsu Photonics K.K. |
Solid composition, microparticles, microparticle dispersion liquid, and manufacturing methods for these
|
US20090098168A1
(en)
*
|
2007-10-08 |
2009-04-16 |
The Regents Of The University Of California |
Multiple-layer microbubble liposphere drug delivery vehicle and system
|
FR2922107B1
(fr)
*
|
2007-10-10 |
2010-02-26 |
Aventis Pharma Sa |
Nouvelles compositions a base de taxoides
|
CA2718416C
(fr)
*
|
2008-03-13 |
2018-01-02 |
Mallinckrodt Inc. |
Dispositif de commande multifonctions actionne a l'aide du pied pour systeme d'imagerie
|
US11304960B2
(en)
*
|
2009-01-08 |
2022-04-19 |
Chandrashekar Giliyar |
Steroidal compositions
|
CN102048688B
(zh)
*
|
2009-10-29 |
2014-03-05 |
中国医学科学院药物研究所 |
以胆固醇复合物为中间载体的紫杉醇亚微乳
|
CN102048725B
(zh)
*
|
2009-10-29 |
2014-07-16 |
中国医学科学院药物研究所 |
紫杉醇胆固醇复合物
|
TWI438009B
(zh)
*
|
2010-02-19 |
2014-05-21 |
Teikoku Pharma Usa Inc |
紫杉烷前-乳劑調配物及其製造與使用之方法
|
CA2798180A1
(fr)
*
|
2010-05-03 |
2011-11-10 |
Teikoku Pharma Usa, Inc. |
Formulations non aqueuses de pro-emulsions a base de taxane et procedes de fabrication et d'utilisation de ces formulations
|
JP2012051823A
(ja)
*
|
2010-08-31 |
2012-03-15 |
Fujifilm Corp |
難容性薬物含有水中油型乳化組成物及びその製造方法
|
US9358241B2
(en)
|
2010-11-30 |
2016-06-07 |
Lipocine Inc. |
High-strength testosterone undecanoate compositions
|
US20180153904A1
(en)
|
2010-11-30 |
2018-06-07 |
Lipocine Inc. |
High-strength testosterone undecanoate compositions
|
US9034858B2
(en)
|
2010-11-30 |
2015-05-19 |
Lipocine Inc. |
High-strength testosterone undecanoate compositions
|
US20120148675A1
(en)
|
2010-12-10 |
2012-06-14 |
Basawaraj Chickmath |
Testosterone undecanoate compositions
|
JO3685B1
(ar)
|
2012-10-01 |
2020-08-27 |
Teikoku Pharma Usa Inc |
صيغ التشتيت الجسيمي للتاكسين غير المائي وطرق استخدامها
|
WO2014208901A1
(fr)
*
|
2013-06-24 |
2014-12-31 |
한국콜마주식회사 |
Composition d'émulsion du type huile dans eau pour médicament faiblement soluble dans l'eau et sa méthode de préparation
|
US20170246187A1
(en)
|
2014-08-28 |
2017-08-31 |
Lipocine Inc. |
(17-ß)-3-OXOANDROST-4-EN-17-YL TRIDECANOATE COMPOSITIONS AND METHODS OF THEIR PREPARATION AND USE
|
US9498485B2
(en)
|
2014-08-28 |
2016-11-22 |
Lipocine Inc. |
Bioavailable solid state (17-β)-hydroxy-4-androsten-3-one esters
|
CN106852118A
(zh)
|
2014-09-19 |
2017-06-13 |
赫伦治疗有限公司 |
阿瑞吡坦乳剂制剂
|
US9974742B2
(en)
|
2016-02-01 |
2018-05-22 |
Heron Therapeutics, Inc. |
Emulsion formulations of an NK-1 receptor antagonist and uses thereof
|
EP3544614A4
(fr)
|
2016-11-28 |
2020-08-05 |
Lipocine Inc. |
Traitement oral à base d'undécanoate de testostérone
|
CN111920782A
(zh)
*
|
2019-05-13 |
2020-11-13 |
中国医学科学院药物研究所 |
复合脂质纳米囊组合物及其制备方法和应用
|